Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia

This study has been terminated.
Information provided by:
Kaohsiung Kai-Suan Psychiatric Hospital Identifier:
First received: October 8, 2009
Last updated: October 18, 2009
Last verified: October 2009